Efficacy and safety of intraprostatic temperature-controlled microwave thermotherapy in patients with benign prostatic hyperplasia: Results of a prospective, open-label, single-center study with 1-year follow-up

Journal of Endourology

Volumn 17, Issue 6, 2003, Pages 425-430

  Gravas, Stavros ^a   Laguna, Maria Pilar ^a   De la Rosette, Jean J M C H ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER SPASM; BODY TEMPERATURE; CLINICAL ARTICLE; CLINICAL TRIAL; DEVICE; DRUG EFFICACY; DRUG SAFETY; FEEDBACK SYSTEM; FEMALE; FOLLOW UP; HUMAN; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE HYPERTROPHY; SCORING SYSTEM; SEXUAL FUNCTION; TRANSURETHRAL MICROWAVE THERMOTHERAPY; TRANSURETHRAL RESECTION; URINARY TRACT INFECTION; URINE VOLUME;

EID: 0043009837     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/089277903767923236     Document Type: Article

References (33)

1. De la Rosette JJMCH, Alivizatos G, Madersbacher S, Perachino M, Thomas D, Desgrandchamps F, de Wildt M. EAU guidelines on benign prostatic hyperplasia (BPH). Eur Urol 2000;40:256-263.
2. D'Ancona FCH, van der Bij AK, Francisca EAE, Kho H, Debruyne FMJ, Kiemeney LA, de la Rosette JJMCH. The results of high energy transurethral microwave thermotherapy in patients categorized according to the American Society of Anesthiologists operative risk classification (ASA). Urology 1999;54:18-22.
3. Wagrell L, Schelin S, Bolmsjo M, Brudin L. Intraprostatic temperature monitoring during transurethral microwave thermotherapy for the treatment of benign prostatic hyperplasia. J Urol 1998;159:1583-1587.
4. Krogh J, Hansen F, Nordling J. Transurethral microwave thermotherapy for the treatment of benign prostatic hyperplasia: Results obtained with the Prostalund device. World J Urol 1998;16:115-119.
5. Schelin S. Microwave thermotherapy in patients with benign prostatic hyperplasia and chronic urinary retention. Eur Urol 2001;39:400-404.
6. De la Rosette JJMCH, de Wildt MJAM, Hofner K, Carter S, Debruyne FMJ, Tubaro A. High energy thermotherapy in the treatment of benign prostatic hyperplasia: Results of the European BPH Study Group. J Urol 1996;156:97-102.
7. Walden M, Acosta S, Carlsson P, Pettersson S, Dahlstrand C. A cost-effectiveness analysis of transurethral resection of the prostate and transurethral microwave thermotherapy for treatment of benign prostatic hyperplasia: Two-year follow-up. Scand J Urol Nephrol 1998;32:204-210.
8. Hallin A, Berlin T. Transurethral microwave thermotherapy for benign prostatic hyperplasia: Clinical outcome after 4 years. J Urol 1998;159:1966-1673.
9. D'Ancona FCH, Francisca EAE, Hendriks JCM, Debruyne FMJ, de la Rosette JJMCH. How to select patients for high energy transurethral microwave thermotherapy? Urology 1999;53:111-117.
10. D'Ancona FCH, Albers YHM, Kiemeney LA, Xue Y, Smedts F, van der Poel HG, Debruyne FMJ, de la Rosette JJMCH. Can histopathology predict treatment outcome following high energy transurethral microwave thermotherapy of the prostate? Results of a biopsy study. Prostate 1999;40:28-36.
11. Thalmann GN, Graber SF, Bitton A, Burkhard FC, Gruenig O, Studer UE. Transurethral thermotherapy for benign prostatic hyperplasia significantly decreases infravesical obstruction: Results in 134 patients after 1 year. J Urol 1999;162:387-393.
12. Djavan B, Bursa B, Basharkhah A, Seitz C, Remzi M, Ghawidel K, Hruby S, Marberger M. Pretreatment prostate-specific antigen as an outcome predictor of targeted transurethral microwave thermotherapy. Urology 2000;55:51-57.
13. Ramsey EW, Dahlstrand C. Durability of results obtained with transurethral microwave thermotherapy in the treatment of men with symptomatic benign prostatic hyperplasia. J Endourol 2000;14:671-675.
14. Ravery V. Transurethral microwave thermotherapy vs transurethral resection of prostate. J Endourol 2000;14:693-696.
15. Carter S, Tubaro A. Relation between intraprostatic temperature and clinical outcome in microwave thermotherapy. J Endourol 2000;14:617-625.
16. De la Rosette JJ, Francisca EA, Kortmann BB, Floratos DL, Debruyne FM, Kiemeney LA. Clinical efficacy of a new 30-min algorithm for transurethral microwave thermotherapy: Initial results. BJU Int 2000;86:47-51.
17. Floratos DL, Kiemeney LA, Rossi C, Kortmann BBM, Debruyne FMJ, de la Rosette JJMCH. Long-term followup of randomized transurethral microwave thermotherapy versus transurethral prostatic tissue resection study. J Urol 2001;165:1533-1538.
18. Terada N, Aoki Y, Ichioka K, Matsuta Y, Okubo K, Yoshimura K, Arai Y. Microwave thermotherapy for benign prostatic hyperplasia with the Dornier Urowave: Response durability and variables potentially predicting response. Urology 2001;57:701-705.
19. Floratos DL, Sedelaar JP, Kortmann BB, Aarnink RG, Wijkstra H, Debruyne FM, de la Rosette JJ. Intra-prostatic vasculature studies: Can they predict the outcome of transurethral microwave thermotherapy for the management of bladder outflow obstruction? Prostate 2001;15;46:200-206.
20. Bolmsjo M, Wagrell L, Hallin A, Eliasson T, Erlandsson BE, Mattiasson A. The heat is on-but how? A comparison of TUMT devices. Br J Urol 1996;78:564-572.
21. Roehrborn CG, Preminger G, Newhall P, et al. Microwave thermotherapy for benign prostatic hyperplasia with the Dornier Urowave: Results of a randomized, double-blind, multicenter, sham-controlled trial. Urology 1998;51:19-28.
22. Eliasson T, Damber JE. Temperature controlled high energy transurethral microwave thermotherapy for benign prostatic hyperplasia using a heat shock strategy. J Urol 1998;160:777-781.
23. Daehlin L, Frugard J. Three-year follow-up after transurethral microwave thermotherapy (TUMT) for benign prostatic hyperplasia using the PRIMUS U + R device. Scand J Urol Nephrol 1999;33:217-221.
24. Albala DM, Fulmer BR, Turk TM, et al. Office-based transurethral microwave thermotherapy using the TherMatrx TMx-2000. J Endourol 2002;16:57-61.
25. Bolmsjo M, Schelin S, Wagrell L, Larson T, de la Rosette JJMCH, Mattiasson A. Cell-kill modeling of microwave thermotherapy for treatment of benign prostatic hyperplasia. J Endourol 2000;14:627-635.
26. Bolmsjo M, Sturesson C, Wagrell L, Anderson-Engels S, Mattiasson A. Optimization of TUMT, using a feedback mechanism. Br J Urol 1998;81:811-816.
27. Francisca EAE, Keijers GB, Floratos DL, Kiemeney LA, Debruyne FMJ, de la Rosette JJMCH. High energy transurethral microwave thermotherapy: Long-term follow up results. (in press).
28. Eliasson T, Abrahamsson L, Pettersson G, Damber JE. Responders and non-responders to treatment of benign prostatic hyperplasia with transurethral microwave thermotherapy. Scand J Urol Nephrol 1995;29:183-191.
29. Brehmer M, Baba S. Transurethral microwave thermotherapy: How does it work? J Endourol 2000;14:611-615.
30. Brehmer M, Hilliges M, Kinn AC. Denervation of periurethral prostatic tissue by transurethral microwave thermotherapy. Scand J Urol Nephrol 2000;34:42-45.
31. De Wildt MJAM, Debruyne FMJ, de la Rosette JJMCH. High-energy transurethral microwave thermotherapy: A thermoablative treatment for benign prostatic obstruction. Urology 1996;48:416-423.
32. Floratos DL, de la Rosette JJMCH. Heat treatment of the prostate: Where do we stand in 2000? Curr Opin Urol 2001;11:35-41.
33. Arai Y, Aoki Y, Okubo K, Maeda H, Terada N, Matsuta Y, Maekawa S, Ogura K. Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function: a prospective study. J Urol 2000;164:1206-1211.